How will you get the corona vaccine?

The total infected in the world is more than

How will you get the corona vaccine?

Dozens of clinical trials are taking place and in some countries these trials have reached the second stage.

Many hope that a

Vaccine Nationalisma

The

As soon as the

Countries like Russia have also made such gestures indirectly. The policy of giving priority to our countries is being called

During the

Professor NK Ganguly, former director general of the

He said, "We can't have that quality vaccine here. Right now the bulk vaccines are being tested in India, we don't know much. If this vaccine is not well, then we should use someone else's vaccine." " Preparation will have to be done from now on because where the vaccine is, it may not be available for other countries. "

Director General of the

He had said, "Vaccination is a great work for the public mind and the good thing is that many efforts are going on. However, there are some countries which are going in the reverse direction and it is a matter of concern. If the mutual agreement vaccine But if not made, then in those countries which have no money or no power, there will be great loss.

How will you get the corona vaccine?

How much control will the vaccine developer have? Under the

But in view of the outbreak of this unexpected epidemic, governments are also adopting the means of "compulsory licensing", so that a third party can make it. That is, the government of the country battling the Corona epidemic may allow some pharmaceutical companies to manufacture it.

The

The Regional Director of WHO in Southeast Asia, Drs. Poonam Khetarpal Singh feels that 'if an effective covid-19 vaccine is produced, it is intended to give two billion doses to people by the end of 2021'. 50% of this will be delivered to countries that fall in the lower and middle income groups. But for this, countries have to improve their systems so that effective methods of delivering medicines to the people are prepared in advance.

Amid waiting for the

On the one hand, while pharmaceutical companies and governments are competing to create an effective covid-19 vaccine, on the other, there is a debate as to who will get it first and who does not. It is clear that the first right after patients will be for health workers, children and the elderly and pregnant women.

Leena Meghani, a longtime pioneer on generic drugs and vaccination in developing countries, is the South Asia head of the MSF Access campaign and believes that "how strong or weak the country's health system is will reflect on vaccination".

Leena Manghani said, "Take the pneumonia vaccine for example, which still reaches only 20% of children in India, the main reason is the price. That is, the Indian government has given this vaccine to Gavi for about $ 10 per child. Have given." Buys from Global Vaccines Alliance. Therefore, apart from a solid health system, the price of any future vaccine will also have a big role ”.

How will you get the corona vaccine?

At the beginning of the covid-19 pandemic, almost all countries of the world agreed to deal with it, but as the process of vaccine research progressed, differences also widened. The differences between governments have to be resolved internationally, but experts believe that a country like India has a population of one and a quarter billion more difficult.

Professor NK Ganguly says, "If I have the vaccine today, I will be very scared and my nights sleep will fly away. It always takes time to bring the vaccine to everyone in India. We have a federal system and all states have to Would be needed. "Now, there may also be a social system between states and those who will not receive the vaccine first".

VK Paul, Member (Health), Government of India NITI Aayog, also spoke on the vaccine this week, saying "the discussion has begun on providing covid-19 vaccine to the needy".

Corona virus changing form, how much effect will the vaccine have?

The

So far, three varieties of the virus have been found in India - the first variety from Wuhan in China, the second from Italy in Europe and the third from Iran.

Researchers are saying that covid-19 infection is spreading rapidly, there is European tension in many regions of the world and it is the type that came out in Italy in the month of February.

The European variety of corona is more powerful than the virus originating from Wuhan in China. But the researchers say that it does not prove that the infection will be more fatal than the European variety of stress.

The emergence of new varieties of the virus will not have a major impact on the discovery of the vaccine.

The

ICMR doctor Raman Gangakhedkar said that "the new virus type will not neutralize the vaccine".

How will you get the corona vaccine?

Upon researching the types of viruses, the institution says it will find out if there has been any change in the strain of the virus during infection in India.

ICMR is a monitoring organization in the field of biomedical research and other matters in India. Currently, policies related to treatment, research, etc. of covid-19 are being formulated only with the guidelines issued by it or with its help.

According to a research by the Scripps Research Institute, infection against the 'European type'

If the number of people going from Europe to America is very large, then it may be the reason for the spread of this type of virus.

US presidential elections are due soon. President Donald Trump has repeatedly attacked China for virus infection. Several Indian leaders have also recently given statements on the virus and China.

The virus that spreads in Italy is not directly related to China.

Genome sequencing (DNA discovery) based on blood samples of 300 people in the Lombardy region found that China had no direct connection with the 'transmission chains' observed there.

Italy banned those coming from China to Italy at the end of January, but only in December symptoms of the virus appeared in the waters of Milan and Turin drains. The newspaper quoted the National Institute of Health of Italy as saying this.

Dr. of Public Health Campaign Gargya Telkapalli says that the virus has life, so it is natural to change it and these changes or new varieties can also be caused by geographical and climatic conditions.

Dr. Gargya Telkapalli states that such changes also occur in other viruses such as influenza and based on those changes, changes are made in the vaccine as well. These changes in the vaccine have been made in the last six months according to the strains and their nature.

The process of sharing genome sequencing continues every day around the world, which is monitored by the